APA-referens (7:e uppl.)

Bombonato, M., Beccuti, G., Benso, A., Giannone, B., Bertaina, S., Broglio, F., & Bioletto, F. (2025). Efficacy and safety of SGLT2 inhibitors in the treatment of maturity-onset diabetes of the young (MODY). Hormones: International Journal of Endocrinology and Metabolism, 1-4. https://doi.org/10.1007/s42000-025-00632-8

Chicago-referens (17:e uppl.)

Bombonato, Michelle, Guglielmo Beccuti, Andrea Benso, Beatrice Giannone, Silvana Bertaina, Fabio Broglio, och Fabio Bioletto. "Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Maturity-onset Diabetes of the Young (MODY)." Hormones: International Journal of Endocrinology and Metabolism 2025: 1-4. https://doi.org/10.1007/s42000-025-00632-8.

MLA-referens (9:e uppl.)

Bombonato, Michelle, et al. "Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Maturity-onset Diabetes of the Young (MODY)." Hormones: International Journal of Endocrinology and Metabolism, 2025, pp. 1-4, https://doi.org/10.1007/s42000-025-00632-8.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.